Neural progenitor cells isolated from the brains of neonatal GFP transgenic mice were grafted to the retina of RCS rats and rds and B6 mice. Expression of GFP and differentiation markers was evaluated at 1-4 weeks post-transplantation. Grafted cells maintained transgene expression throughout the 4-week period. At 1 week there was widespread migration of GFP + cells within the host retina and at 2 weeks evidence of neuronal differentiation (as shown by both marker expression and cell morphology), although integration at 4 weeks was limited to syngeneic recipients. Because brain-derived neural progenitor cells exhibit both neuronal and astrocytic differentiation in diseased and normal host retina, these cells provide a useful tool for studies of retinal regeneration.
Introduction
Neural stem or progenitor cells are immature, multipotent cells that have the capacity to differentiate into the three CNS lineages (neurons, astrocytes, and oligodendrocytes). Numerous recent reports have demonstrated the high degree of plasticity these cells possess, specifically in the setting of neuronal transplantation (Brustle et al., 1998; Flax et al., 1998; Gage et al., 1995) . Photoreceptors have been transplanted into the host retina using either cell suspensions (Gouras, Du, Kjeldbye, Yamamoto, & Zack, 1994) or intact sheets (Seiler & Aramant, 1998; Silverman & Hughes, 1989) . Recently, limited evidence of graft-host integration has been shown (Ghosh, Bruun, & Ehinger, 1999; Zhang, Arner, Ehinger, & Perez, 2003) , although there remains some debate regarding the significance of this integration (Berson & Jakobiec, 1999) . On the other hand, neural progenitor cells (NPCs) isolated from rodents (Palmer, Takahashi, & Gage, 1997) or human brain (Sabate et al., 1995) have been transplanted to various sites within the central nervous system (CNS) and frequently exhibit a greater tendency towards integration than other, more committed, cell types.
The daunting problem of limited graft-host integration in the mature retina has been overcome by the use of stem cells isolated from the adult rodent hippocampus (Young, Ray, Whiteley, Klassen, & Gage, 2000) . In these studies, transplanted NPCs derived from the adult rat hippocampus exhibited a high degree of integration within the host retina and adopted morphologies and positions appropriate to native retinal cells. This integration was seen following transplantation to both normal developing (Takahashi, Palmer, Takahashi, & Gage, 1998) and diseased adult retina (Young et al., 2000) . Despite the striking morphological findings, however, hippocampal progenitor cells were unable to differentiate into mature, rhodopsin-expressing photoreceptors.
When transplanting cells to the CNS, it is vital that the cells in question be unequivocally marked, so as to permit definitive identification of grafted cells that have migrated and/or integrated within the host milieu. In the studies cited above, adult rat hippocampal progenitor cells were modified post-isolation to express enhanced green fluorescent protein (eGFP) or Lac-Z reporter genes for this purpose.
It would be advantageous to derive the cells from mouse donors, in order to take advantage of the numerous transgenic and disease models available in this species. Cells obtained from mice transgenic for a reporter gene should maintain expression of the marker following differentiation. Furthermore, in the case of soluble proteins, this label should reveal the structure of fine neuronal processes. It is also important that the cells express the reporter gene prior to isolation, without the need for subsequent viral or genetic modification which can decrease cell viability and potentially result in unpredictable ontogenetic sequellae, such as uncontrolled proliferation. Neural stem cells isolated from the GFP transgenic mouse fulfill these criteria and have been shown to maintain expression of the reporter gene after grafting to diseased syngeneic recipients (Lu et al., 2002) . Here we investigate the fate of brain-derived GFP + NPCs after grafting into the eyes of rodents. Included are mature normal syngeneic B6 mice and two extensively studied models of retinal degeneration, namely, mature dystrophic allogeneic rds BALB/C mice and mature dystrophic xenogeneic RCS rats.
Materials and methods

Donor cell line
Animals were treated according to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. NPCs were isolated from the brain of postnatal day 1 green fluorescent protein (GFP) transgenic B6 mice (Okabe, Ikawa, Kominami, Nakanishi, & Nishimune, 1997) and maintained using methods previously described (Lu et al., 2002) . Briefly, whole-brain homogenates were incubated in 0.1% collagenase and single-cell suspensions obtained. Dissociated cells were then cultured in DMEM/F12 supplemented with N-2 (Gibco) and 20 ng/ml of both epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF). Cultures rapidly generated neurospheres that could in turn be dissociated and subcultured to regenerate new spheres.
Cells were cultured under these conditions for up to 1 year without any evidence of senescence or mitogenindependent proliferation. However, as late passage cells have shown a tendency to differentiate into cells of astrocytic lineage in vitro, all cells used for transplantation were taken from early passages (<15), or from early passage populations that were stored at )150°C in 10% DMSO and subsequently thawed. Freezing and thawing could be achieved with high viability (95%) and no apparent impact on self-renewal or multipotency.
Differentiation and characterization of donor cell line in vitro
To examine the differentiation of GFP expressing NPCs in vitro, several spheres were plated into 24 well dishes in DMEM/F12 medium supplemented with 10% fetal bovine serum. Cultures were fixed with 4% paraformaldehyde at 3 days, 1 week, 2 weeks and 4 weeks after plating. Cultures were blocked in 1% BSA + 0.2% Triton-100 or 1% BSA + 10% normal goat serum for 30 min, then incubated for 2 h with primary antibody for anti-GFP (1:1000, marker for GFP expressing cells, Clontech), Ki-67 (1:100, cell proliferation marker, Vector), nestin (1:1, immature neuronal marker, DSHB, Iowa), GFAP (1:50, astrocytic marker, Dako), MAP-2 or NF-200 (1:500 and 1:1000, respectively, neuronal markers, Sigma), GalC (1:100, oligodendrocytic marker, Sigma), TH (1:200, dopaminergic neurons, Sigma), 2D4 (1:500, rhodopsin marker; kind gift of Dr. R. Molday, University of BC, Canada) or calbindin (1:1000, amacrine cell marker, Sigma). After rinsing in PBS, samples were incubated in Cy3-conjugated species-specific IgG (1:150) for 1 h. Samples were rinsed again and then coverslipped in PVA/Dabco and viewed under fluorescent illumination.
Recipient animals and transplantation
NPCs derived from the brain of GFP transgenic mice were transplanted to the eye of animals under general (ketamine/xylazine; mouse dosage 120 mg/kg ketamine, 10 mg/kg xylazine, IP; rat dosage 60 mg/kg ketamine, 5 mg/kg xylazine, IP) plus topical (proparacaine) anesthesia. One-2 ll injections of DMEM/F12 media containing 5-10 small to medium sized spheres (10,000-20,000 cells) were delivered to the subretinal space of rds BALB/C mice (3 weeks, n ¼ 4; 7 weeks, n ¼ 18), normal B6 mice (7 weeks, n ¼ 12), and pigmented dystrophic RCS rats (24-30 days, average age 27.5 days, n ¼ 20). The host pupil was dilated using a drop of topical tropicamide (1%). Injections were made with a sharp beveled glass micropipette (outside diameter 1 mm) connected with PE tubing to a 50 ll Hamilton microsyringe, and performed under direct observation using coaxial illumination via a binocular surgical microscope (M€ o oller). The sharp tip of the micropipette allowed direct entry to the vitreous or subretinal space through a self-sealing wound, the entry point being just vitread to the corneo-scleral junction. This approach avoided trauma to the ciliary body and lens, but necessarily resulted in focal perforation of the intervening uvea and peripheral retina. At the time of surgery it was noted that injections often resulted in the introduction of spheres to the vitreal cavity as well as the subretinal space.
As a control, nonviable cells that had been freezethawed three times were also injected (n ¼ 3, BALB/c, n ¼ 3, B6). At 1, 2 and 4 weeks post-transplantation (only 1 week time point for 3 week old BALB/c recipients), eyes were removed and immersion fixed with 4% paraformaldehyde, cryoprotected with 20% sucrose and frozen in embedding media. Eyes were sectioned at 6-8 lm on a cryostat; approximately 400-500 sections were made per eye. Sections were processed with primary antibodies (see above) for 2 h, followed by reaction with species-specific IgG conjugated to Cy3 (1:150) for 1 h. Photomicrographs of sections were taken by confocal microscopy.
Results
Differentiation and characterization of donor cells in vitro
When grown in media supplemented with mitogens, the NPCs expressed high levels of GFP ( Fig. 1A and B) and maintained an undifferentiated state characterized by near ubiquitous expression of Ki-67 and nestin immunoreactivity (data not shown). Cells could be maintained in this state for up to one year in culture. To examine differentiation in vitro, NPCs were withdrawn from growth factors and cultured as neurospheres in the presence of 10% FBS for 3, 7, 14 and 28 days. The number of cells expressing Ki-67 markedly decreased in the presence of serum. Ki-67 immunoreactivity was seen in most spheres at Day 7, far fewer at Day 14, and was absent by day 28 (data not shown). NPCs were also examined for nestin, NF-200, GFAP and GalC ( Fig. 1) . At Day 3, the cells expressed high levels of nestin and GFAP, low levels GalC but very little G, K and O) . At Day 7, cells had begun to migrate away from the adherent sphere and increased in both size and stage of morphological differentiation (Fig. 1D , H, L and P). At this time, NF-200 expression was first observed ( Fig. 1H) . At Day 14, the cells extended numerous long processes positive for the cytoskeletal markers nestin (Fig. 1E ), NF-200 ( Fig. 1I ), or GFAP ( Fig. 1M) . At day 28, a particularly striking feature was the high level of NF-200 expression, both in the central region of the explant and the long neurite-like processes ( Fig. 1J ). At this time point, levels of nestin were much reduced while the cells continued to express high levels of GFP (data not shown) as well as moderate levels of GFAP or GalC (Fig. 1F, 1N and 1R ). Unlike NF-200, however, expression of GalC and, to a lesser extent, GFAP was confined to a subpopulation of cells that had migrated away from the differentiating neurosphere. Table 1 shows survival and integration of grafted NPCs in the eye of non-immunosuppressed host animals at 1, 2 and 4 weeks post-transplantation. In syngeneic B6 mice and allogeneic rds BALB/C mice, surviving NPCs could be found in almost all recipient eyes at all three time points (total 33/34; 97%). In xenogeneic RCS rat hosts, survival of donor cells was decreased at both of the later time points.
The fate of transplanted donor cells
In addition to surviving, GFP-expressing NPCs frequently migrated into the host retina where they showed signs of morphological integration. At 1, 2 and 4 weeks post-grafting, integrated NPCs were found in 80%, 67% and 0% of adult rds BALB/C mice; 50%, 100% and 100% of adult normal B6 mice; and 60%, 67% and 0% of adult RCS rats, respectively.
Although GFP + cells were readily identified under FITC illumination, donor origin was confirmed by anti-GFP immunoreactivity (data not shown) as well as constitutive GFP expression. Grafted cells were distinguished from the autofluorescence of host photoreceptor outer segments based upon morphology, intensity, and specificity of the signal. No evidence of viable donor cells, or host GFP expression, was seen following injection of freeze-thawed GFP + NPCs. Importantly, there was no evidence of host expression of the GFP marker, e.g., fully differentiated retinal cells expressing GFP, as might be predicted had fusion occurred between cells of graft and host.
Normal B6 recipients
One week following delivery to the subretinal space of normal B6 mice, grafted cells had migrated into the outer plexiform, inner nuclear, and inner plexiform layers, and the majority were found to express nestin ( Fig. 2A-C ) and many cells were positive for GFAP ( Fig. 2D-F) . Two weeks following grafting, GFP + cells showed widespread migration involving all retinal layers ( Fig. 2G-I ), together with co-localized nestin and GFAP expression in the inner nuclear and inner plexiform layers. The morphology and distribution of grafted cells were strikingly similar to resident retinal cells of the host (Fig. 2G-I) . Also seen at this time point was expression of MAP-2 in the inner nuclear layer (Fig. 2J-L) and NF-200 in the nerve fiber layer (Fig. 2M-O) , although only a small subpopulation (<5%) of surviving cells expressed these markers. Host M€ u uller cells showed upregulation of GFAP near the injection site (Fig.  2G-I) .
Four weeks after grafting, GFP + cells continued to display widespread migration and appeared more differentiated morphologically than at 2 weeks post-grafting. MAP-2 and NF-200 positive cells were seen in the inner nuclear layer (Fig. 3A-I) , with a few nestin or GFAP positive cells present in the inner plexiform layer (Fig. 3A-C) . MAP-2 and NF-200 + cells were also seen in the nerve fiber layer (Fig. 3G-I ). Neuronal markers, while found in all animals examined, were rare relative to the number of surviving cells, with fewer than 5% expressing MAP-2 or NF-200. Expression of GFP by grafted cells remained constant for at least 4 weeks.
rds recipients
One week following injection into the vitreous cavity of rds BALB/C mice, neurospheres had adhered to the inner surface of the retina and GFP + cells had already begun to migrate into the host retina (Fig. 4A-C) . In cases where neurospheres were injected into the subretinal space, GFP + cells had migrated into the ganglion cell and inner plexiform layers where they extended numerous long processes and expressed GFAP and nestin (Fig. 4A-F) .
Two weeks following grafting, GFP + cells were found in the ganglion cell layer and inner plexiform layer. Donor cells expressed nestin (Fig. 4G-I) , GFAP (Fig.   4J-L) , and although a few (less than 1% of surviving cells, much less than was seen in B6 hosts) may have expressed low levels of NF-200 or MAP-2, it was not possible to definitively demonstrate expression of these markers.
Four weeks following grafting to rds BALB/C mice, no GFP + cells were found in the host retina, although GFP + cells were present in the vitreous cavity and subretinal space. rds BALB/C 7-Week old n ¼ 18
In syngeneic B6 mice and allogeneic rds BALB/C mice, surviving NPCs could be found in most eyes at all 3 time points. In xenogeneic RCS rats, surviving cells were found in fewer animals at 2 and 4 weeks post-transplantation. No integration was seen at the 4 week time point in allo-and xenogeneic recipients. 
RCS rat recipients
One week following grafting into the subretinal space of RCS rats, donor cells were found within most layers of the host retina, particularly the plexiform layers ( Fig.  5A-C) . Grafted cells appeared to have entered the retina through defects in the inner/outer segment layer. At this time point, GFP + cells were present in the outer nuclear layer (where they co-expressed GFAP; Fig. 5A-C) , the outer plexiform layer, the inner nuclear layer (where they co-expressed MAP-2; Fig. 5D-F) , and the outer plexiform layer (where they again co-expressed GFAP; Fig. 5A-C) . Cells transplanted to rat hosts rarely expressed neuronal markers, as was the case for cells transplanted to mouse recipients, with less than 1% of surviving cells showing MAP-2 or NF-200 expression.
Two weeks following grafting, GFP + cells showed a similar distribution as at 1 week, but fibers became more prominent and exhibited a more differentiated morphological pattern. MAP-2 co-expressing cells located in the inner nuclear layer sent long processes into the inner plexiform layer (Fig. 5G-I ) and host M€ u uller cells again showed upregulation of nestin near the injection site (Fig. 5J-L) . Nestin co-expressing cells located in the inner nuclear layer sent long, wide processes to the inner plexiform layer where they arborized into numerous narrow fibers (Fig. 5J-L) . Many grafted cells expressing GFAP were seen, although the morphology was often not similar to that normally seen in the retina (Fig. 5M-O) . NF-200 co-expressing cells located in the inner nuclear layer often extended long neurites into the host optic nerve fiber bundles (Fig. 5P-R) .
Four weeks following grafting to RCS rats, no donor cells were found in the host retina, although many GFP + cells could be seen in the subretinal space or vitreous of host eyes. Constitutive GFP expression was maintained for at least 4 weeks.
All recipients
No expression of Ki-67 by grafted NPCs was observed within the retina of any recipient animals and none of the grafted cells expressed TH, 2D4 or calbindin (markers for specific retinal cell types).
Discussion
The cells described in this work express a GFP transgene and are capable of generating neurospheres, sustaining high levels of proliferation, and maintaining an immature (nestin+) state in the presence of EGF and bFGF. These cells are also capable of differentiation into all three neural lineages (i.e., neurons, astrocytes and oligodendrocytes; confirmed by expression of microtubule-associated protein-2 (MAP-2), glial fibrillary acidic protein (GFAP), and the oligodendrocyte marker galactocerebroside (GalC) respectively). These properties meet some, but not all, criteria for a ''neural stem cell'' and as such are described herein as NPCs.
While rat derived NPCs have been successfully modified in culture with retroviruses to stably express GFP (Young et al., 2000) , we and others have been less successful in generating stable lines from mouse and human Fig. 3 . Confocal images of expression of neural markers by NPCs grafted to the eye of normal adult B6 mice at 4 weeks post-grafting. NPCs were grafted to 7-week old normal adult B6 mice hosts and examined at 4 weeks. (A-C) GFAP co-expressing NPCs extend numerous fibers in the inner plexiform layer at 4 weeks after grafting. (D-F) NF-200 co-expressing NPC extends long, thick processes both symmetrically and horizontally at the border between the inner nuclear layer and inner plexiform layer at 4 weeks after grafting. (G-I) MAP-2 co-expressing NPCs in the inner nuclear layer and nerve fiber layer at 4 weeks after grafting. Bar ¼ 100 lm.
progenitor populations . Shutdown of reporter gene expression following differentiation, and toxic levels of the reporter protein are serious problems with the approach of post-isolation modification, and the use of transgenic animals ubiquitously expressing reporter genes offers a new avenue of cell labeling for transplantation. In this and other studies we have performed, we have not seen any evidence of reporter shutdown, unlike that seen with ex-vivo labeling .
In previous work, we and others have described an apparent ''injury response'' exhibited by rat hippocampal progenitor cells following transplantation to the CNS. While we cannot rule out the possibility that the cells in the present study responded to injuries caused by the injection procedure in preference to cues from the dystrophic process, it seems apparent that here the grafted progenitor cells survived and differentiated better in the normal syngeneic than in the diseased immunologically disparate hosts. There are a number of possible explanations for this result.
Firstly, one must consider a classical immune response to foreign tissue, as the normal B6 hosts were syngeneic, whereas dystrophic animals were either alloor xenogeneic. Indeed, in another study addressing this concern we saw excellent survival of grafted mouse NPCs in diseased, syngeneic recipients (Lu et al., 2002) . However, our previous work in rats indicated a strong injury response, with excellent survival even in the setting of allogeneic disparity (Young et al., 2000) , perhaps reflecting the stronger immune response commonly observed in the mouse as compared to the rat.
Other considerations include donor cell-specific issues related to survival. The NPCs here were grafted as small to medium spheres containing approximately 1000-5000 cells, with approximately 10,000-20,000 cells grafted per eye. In addition, efflux of cells from the injection site into the vitreous or even one round of cell division after The combination of these and other potential variables make estimating cell survival difficult in this setting. We have, however, begun a more systematic assessment of cell survival and, despite the above cited difficulties, found that survival of GFP + mouse NPCs in normal, syngeneic recipients was quite low, on the order of 5-10% at 2 weeks, dropping to about 2-5% at 4 weeks. In allogeneic and xenogeneic recipients, these numbers are further reduced by more than 50%. While these figures are not unexpected based on other stem cell grafting studies (where figures as low as 0.1 have been reported), they are notably low when compared to our experience with hippocampal progenitor cells in the rat (where >50% of the cell survived for 4 weeks) or when grafting the mouse cells described here to the brain or spinal cord. The only current clinical application of neural transplantation is for ParkinsonÕs Disease, where a similar level of cell survival (10%) has been reported (Brundin, Dunnett, Bjorklund, & Nikkhah, 2001 ) and a great deal of recent work has focused on increasing graft viability Emgard, Karlsson, Hansson, & Brundin, 1999; Mundt-Petersen, Petersen, Emgard, Dunnett, & Brundin, 2000; Petersen, Emgard, & Brundin, 1999) . While it is difficult to compare studies such as these, a fundamental goal of future stem cell transplantation research should be to address the difficult problem of assessing progenitor cell survival, thereby laying the groundwork for methods aimed at optimizing the survival of cells grafted to the CNS.
A remaining potential variable that deserves attention is donor cell-specific developmental potential. For instance, even if cell survival were increased to 100%, neural progenitor transplants would be of little benefit without appropriate differentiation and synaptic integration. As was the case with previous studies by us Young et al., 2000) and others (Warfvinge, Kamme, Englund, & Wictorin, 2001; Wojciechowski, Englund, Lundberg, & Warfvinge, 2002 ), brain-derived cells seem unwilling to differentiate into authentic retinal neurons. With the recent isolation of stem cells from the mammalian neuroretina (Ahmad, Dooley, Thoreson, Rogers, & Afiat, 1999; Shatos et al., 2001 ) and ciliary margin zone (Ahmad, Tang, & Pham, 2000; Tropepe et al., 2000) , however, it may now be possible to make new retinal cells. Additional approaches, including modification of retinal and iris pigmented epithelial cells (Haruta et al., 2001) , or modification of embryonic stem (ES) cells, may also provide fruitful avenues of investigation.
Finally, the problem of graft-host connectivity must be addressed. While we and others have shown evidence suggestive of graft-host integration (Young et al., 2000) , and retinal stem cells have the capacity to generate voltage-gated currents appropriate for functional neurons (Ahmad et al., 1999) , functional integration of grafted stem cells with the host CNS has yet to be demonstrated. This of course presupposes that grafted stem cells have the capacity to differentiate into fully mature, functional neurons capable of making functional connections. Again, this has yet to be demonstrated. Perhaps the best evidence for this to date comes not from transplantation studies, but from induction of endogenous stem cells in the mature rodent cortex, where newly born neocortical neurons were shown to be synaptically connected to the host thalamus (Magavi, Leavitt, & Macklis, 2000) . There is also a great deal to learn from the visual systems of lower vertebrates, where endogenous stem cells have the capacity to form new retina in fish (Otteson, DÕCosta, & Hitchcock, 2001; Wu et al., 2001) , and perhaps birds (Fischer & Reh, 2001) .
If stem cell therapy is to be of use for the repair of the diseased central nervous system, we must first understand the cell biology underlying the appropriate integration, differentiation and connectivity with the mature brain, spinal cord, and retina. Much work remains to be done, but the many advances being made by laboratories around the world provide hope that it may be possible to grow new cells that will replace those lost due to injury or disease.
